These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33194825)

  • 21. Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against
    Palucci I; Maulucci G; De Maio F; Sali M; Romagnoli A; Petrone L; Fimia GM; Sanguinetti M; Goletti D; De Spirito M; Piacentini M; Delogu G
    Front Immunol; 2019; 10():3042. PubMed ID: 32038614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage susceptibility to infection by Ghanaian
    Osei-Wusu S; Tetteh JKA; Musah AB; Ntiamoah DO; Arthur N; Adjei A; Arbues A; Ofori EA; Mensah KA; Galevo SEA; Frempong AF; Asare P; Asante-Poku A; Otchere ID; Kusi KA; Lenz TL; Gagneux S; Portevin D; Yeboah-Manu D
    Front Cell Infect Microbiol; 2023; 13():1163993. PubMed ID: 37645380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in
    Nore KG; Jørgensen MJ; Dyrhol-Riise AM; Jenum S; Tonby K
    Front Immunol; 2020; 11():579849. PubMed ID: 33304347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy.
    Ahmed MIM; Ntinginya NE; Kibiki G; Mtafya BA; Semvua H; Mpagama S; Mtabho C; Saathoff E; Held K; Loose R; Kroidl I; Chachage M; von Both U; Haule A; Mekota AM; Boeree MJ; Gillespie SH; Hoelscher M; Heinrich N; Geldmacher C
    Front Immunol; 2018; 9():2247. PubMed ID: 30323818
    [No Abstract]   [Full Text] [Related]  

  • 27. The C-Type Lectin Receptor DC-SIGN Has an Anti-Inflammatory Role in Human M(IL-4) Macrophages in Response to
    Lugo-Villarino G; Troegeler A; Balboa L; Lastrucci C; Duval C; Mercier I; Bénard A; Capilla F; Al Saati T; Poincloux R; Kondova I; Verreck FAW; Cougoule C; Maridonneau-Parini I; Sasiain MDC; Neyrolles O
    Front Immunol; 2018; 9():1123. PubMed ID: 29946317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of antibody responses against Mycobacterium tuberculosis antigen Rv0679c in tuberculosis patients from the endemic and non-endemic regions of the Beijing genotype: a case control study.
    Zhao J; Matsuba T; Zhang X; Leano S; Nakajima C; Chagan-Yasutan H; Telan EF; Suzuki Y; Hattori T
    BMC Infect Dis; 2017 May; 17(1):344. PubMed ID: 28506215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of non-coding RNA on macrophage modification in tuberculosis infection.
    Wang Z; Xu H; Wei Z; Jia Y; Wu Y; Qi X; Li Y; Gao X
    Microb Pathog; 2020 Dec; 149():104592. PubMed ID: 33098931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Functional Role for Antibodies in Tuberculosis.
    Lu LL; Chung AW; Rosebrock TR; Ghebremichael M; Yu WH; Grace PS; Schoen MK; Tafesse F; Martin C; Leung V; Mahan AE; Sips M; Kumar MP; Tedesco J; Robinson H; Tkachenko E; Draghi M; Freedberg KJ; Streeck H; Suscovich TJ; Lauffenburger DA; Restrepo BI; Day C; Fortune SM; Alter G
    Cell; 2016 Oct; 167(2):433-443.e14. PubMed ID: 27667685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomic analysis of infected primary human leucocytes revealed PSTK as potential treatment-monitoring marker for active and latent tuberculosis.
    Kaewseekhao B; Roytrakul S; Yingchutrakul Y; Salao K; Reechaipichitkul W; Faksri K
    PLoS One; 2020; 15(4):e0231834. PubMed ID: 32298370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoniazid-induced control of Mycobacterium tuberculosis by primary human cells requires interleukin-1 receptor and tumor necrosis factor.
    Yamashiro LH; Eto C; Soncini M; Horewicz V; Garcia M; Schlindwein AD; Grisard EC; Rovaris DB; Báfica A
    Eur J Immunol; 2016 Aug; 46(8):1936-47. PubMed ID: 27230303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Mycobacterium tuberculosis-specific antibody responses for the discrimination of active and latent tuberculosis infection.
    Wang S; Wu J; Chen J; Gao Y; Zhang S; Zhou Z; Huang H; Shao L; Jin J; Zhang Y; Zhang W
    Int J Infect Dis; 2018 May; 70():1-9. PubMed ID: 29410147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection.
    Wayengera M; Kateete DP; Asiimwe B; Joloba ML
    BMC Infect Dis; 2018 Mar; 18(1):133. PubMed ID: 29548281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dormant Mycobacterium tuberculosis fails to block phagosome maturation and shows unexpected capacity to stimulate specific human T lymphocytes.
    Mariotti S; Pardini M; Gagliardi MC; Teloni R; Giannoni F; Fraziano M; Lozupone F; Meschini S; Nisini R
    J Immunol; 2013 Jul; 191(1):274-82. PubMed ID: 23733870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood M2a monocyte polarization and increased formyl peptide receptor 1 expression are associated with progression from latent tuberculosis infection to active pulmonary tuberculosis disease.
    Chen YC; Chang YP; Hsiao CC; Wu CC; Wang YH; Chao TY; Leung SY; Fang WF; Lee CP; Wang TY; Hsu PY; Lin MC
    Int J Infect Dis; 2020 Dec; 101():210-219. PubMed ID: 32971238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of Th1/Tc1 and Th17/Tc17 responses in pulmonary tuberculosis by IL-20 subfamily of cytokines.
    Kumar NP; Moideen K; Banurekha VV; Nair D; Babu S
    Cytokine; 2018 Aug; 108():190-196. PubMed ID: 29684756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B cells response directed against Cut4 and CFP21 lipolytic enzymes in active and latent tuberculosis infections.
    Rénier W; Bourdin A; Rubbo PA; Peries M; Dedieu L; Bendriss S; Kremer L; Canaan S; Terru D; Godreuil S; Nagot N; Van de Perre P; Tuaillon E
    PLoS One; 2018; 13(4):e0196470. PubMed ID: 29709002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.